KRAS and familial pancreatic carcinoma: The KRASG12R mutational isoform is uniquely more prevalent in pancreas cancer compared to other KRAS-driven solid organ cancers and was previously shown to be a negative prognostic factor for overall survival compared to pancreatic cancers with KRAS G12D or G12V mutations [17, 18].